Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03368651
PHASE3
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Sponsor: Sun Yat-sen University
View on ClinicalTrials.gov
Summary
To compare the impact on survival of neo-adjuvant TAI for patients with HCC and PVTT who underwent hepatectomy.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
230
Start Date
2016-01-01
Completion Date
2028-12-31
Last Updated
2017-12-11
Healthy Volunteers
No
Conditions
Interventions
PROCEDURE
TAI
transarterial chemoinfusion with mFOLFOX6 (oxaliplatin, calcium folinate, and 5-FU)
Locations (1)
Cancer Center of Sun Yat-Sen University
Guangzhou, Guangdong, China